Millennium Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Millennium Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8,000	Closed	-$2.53M	–	6813
2023 Q4	$2.53M	Sell	8,000 -9,200	-53%	-$1.79M	﹤0.01%	3406
2023 Q3	$2.91M	Sell	17,200 -23,400	-58%	-$4.4M	﹤0.01%	3216
2023 Q2	$8.8M	Buy	+40,600	New	+$8.7M	﹤0.01%	2144
2022 Q3	–	Sell	-39,000	Closed	-$4.93M	–	7636
2022 Q2	$4.93M	Buy	+39,000	New	+$4.48M	﹤0.01%	2828

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Millennium Management's KRTX Position: Q1 2024 in Review

Millennium Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 162,991 shares — an estimated $51.6M sold.

Millennium Management first reported a position in KRTX in Q2 2019 and held it in 15 quarters. The position peaked at $51.6M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Millennium Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Millennium Management sold 162,991 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $51.6M.
Millennium Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2019 and held it in 15 quarters.
Millennium Management's Karuna Therapeutics, Inc. Common Stock position peaked at $51.6M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.